Non-invasive, autonomous robotic platform
Total Trials
11
As Lead Sponsor
10
As Collaborator
1
Total Enrollment
5,424
NCT01775488
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)
Phase: N/A
Role: Lead Sponsor
Start: Jun 30, 2013
Completion: Not specified
NCT01896973
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Start: Jul 31, 2013
Completion: Dec 31, 2016
NCT03741088
Study to Evaluate VORTX Rx (Theresa)
Start: Mar 21, 2018
Completion: Jul 17, 2019
NCT04572633
The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy
Start: Jan 27, 2021
Completion: Sep 30, 2027
NCT04573881
The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)
Start: Jun 4, 2021
Completion: Aug 31, 2027
NCT05432232
The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
Start: Mar 23, 2023
Completion: Jun 6, 2025
NCT05820087
The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)
Start: Jan 4, 2024
Completion: Jul 31, 2030
NCT06486454
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Start: Oct 14, 2024
Completion: Nov 30, 2031
NCT06282809
The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy
Start: Dec 10, 2024
Completion: Jul 31, 2026
NCT07044362
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Role: Collaborator
Start: Jun 30, 2025
Completion: Apr 1, 2028
NCT07214675
The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy
Start: Mar 31, 2026
Completion: Oct 31, 2027
Loading map...